Detalhe da pesquisa
1.
Reduced severity of SARS-CoV-2 infection by Kappa variant of interest (B.1.617.1) in a healthcare worker post-vaccination from Gujarat, India.
Indian J Med Res
; 155(5&6): 575-577, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35975349
2.
Host immune responses in aged rhesus macaques against BBV152, an inactivated SARS-CoV-2 vaccine, and cross-neutralization with beta and delta variants.
Front Immunol
; 14: 1161571, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37187744
3.
Broadly Reactive SARS-CoV-2-Specific T-Cell Response and Participation of Memory B and T Cells in Patients with Omicron COVID-19 Infection.
J Immunol Res
; 2023: 8846953, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37881339
4.
Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant.
Hum Vaccin Immunother
; 18(6): 2127289, 2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36170667
5.
A case with SARS-CoV-2 reinfection from India.
Indian J Med Microbiol
; 40(1): 166-168, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34789389
6.
Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months.
Hum Vaccin Immunother
; 18(7): 2156753, 2022 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36576223
7.
Zika a Vector Borne Disease Detected in Newer States of India Amidst the COVID-19 Pandemic.
Front Microbiol
; 13: 888195, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35756041
8.
SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera.
J Infect
; 84(4): e36-e38, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35192896
9.
Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination.
J Infect
; 85(1): 90-122, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35461911
10.
Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees.
J Infect
; 84(6): 834-872, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35318093
11.
Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concern.
J Infect
; 84(5): e80-e81, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35157945
12.
Immune responses against different variants of SARS-CoV-2 including Omicron following 6 months of administration of heterologous prime-boost COVID-19 vaccine.
J Travel Med
; 29(3)2022 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35244698
13.
Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2.
J Travel Med
; 28(4)2021 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33772577